Superior Surgical Oncology Education – Visit ExpertEd@SSO

ExpertED LogoExpertEd@SSO delivers innovative surgical oncology education developed by preeminent surgical oncology leaders to support professional development and understanding of complex clinical issues. The following educational programs are now available or coming soon:

Multidisciplinary Management of Locoregional Metastasis from Melanoma
In-transit melanoma is defined as the development of many tumor nodules between the primary tumor and the regional nodal basin. Although in-transit melanoma is uncommon, the disease has a high risk of recurrence, disease progression and metastasis. This webinar offers one (1) AMA PRA Category 1 Credit and one (1) MOC self-assessment credit that may be applied toward Part 2 of the American Board of Surgery (ABS) MOC Program. This activity is supported by an educational grant by Amgen.

Cut-to-the-Case: Complex Cases in Cancer Surgery
This quick 45-minute webinar addresses three of the most current and controversial issues in surgical oncology. It includes short, focused discussions on the evolving indications for neoadjuvant chemotherapy in gastric cancer, updates in the management of desmoid tumors, and what surgeons should know about molecular testing in colorectal cancer. This program features cases by Daniel G. Coit, MD, David Shibata, MD and Aimee M. Crago, MD and moderated by David L. Bartlett, MD and Daniel G. Coit, MD. These experts, each in their respective field, present up-to-date practical recommendations for management of these common problems. This webinar is an ideal resource for cancer surgeons in the community.

Checkpoint Inhibitors as Immunotherapy
Coming this Spring, this new educational review series will highlight the mechanisms and principles of checkpoint inhibitors and the results of using checkpoint inhibitors in patients with advanced cancer. Biomarkers for selecting patients and interpreting results of immunotherapy, as well as surgical management of complications of immunotherapy will be reviewed. Finally, the rationale and emerging use of neoadjuvant immunotherapy and genetically modified vectors of immunotherapy in combinations with checkpoint inhibitors will be discussed.

A total of seven articles are part of this educational series and will offer 7.5 AMA PRA Category 1 Credits™ and 7.5 MOC Part 2 Credits. The articles will be published in the Annals of Surgical Oncology and available in ExpertEd@SSO. Charles M. Balch, MD and Howard Kaufman, MD served as Editors for the multi-article series.

Other Articles
Scroll to Top